Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome Ahmed M. Mohamadin, Fawzia A. Habib, Thoraya Fadul Elahi Pathophysiology Volume 17, Issue 3, Pages 189-196 (June 2010) DOI: 10.1016/j.pathophys.2009.11.004 Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions
Fig. 1 Serum paraoxonase 1 (PON1) activity in women with polycystic ovary syndrome (PCOS) and healthy controls. *Significantly different from healthy control (p<0.01). Pathophysiology 2010 17, 189-196DOI: (10.1016/j.pathophys.2009.11.004) Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions
Fig. 2 Serum malondialdehyde (MDA) levels in women with polycystic ovary syndrome (PCOS) and healthy controls. *Significantly different from healthy control (p<0.01). Pathophysiology 2010 17, 189-196DOI: (10.1016/j.pathophys.2009.11.004) Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions
Fig. 3 Serum total antioxidant status (TAS) in women with polycystic ovary syndrome (PCOS) and healthy controls. *Significantly different from healthy control (p<0.01). Pathophysiology 2010 17, 189-196DOI: (10.1016/j.pathophys.2009.11.004) Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions
Fig. 4 Correlation coefficient between HOMA-IR (A), testosterone (B), FAI (C), MDA (D), TAS (E), HDL-C (F) and serum PON1 activity Serum in women with polycystic ovary syndrome. Pathophysiology 2010 17, 189-196DOI: (10.1016/j.pathophys.2009.11.004) Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions